Highlights
Safety and efficacy of eraser laser enucleation of the prostate
Tuesday, 25 October 2011- A group of Austrian researchers conducted a study with the aim to ascertain the safety and efficacy of the 1,318 nm diode Eraser laser (Rolle and Rolle, Salzburg, Austria) for transurethral enucleation...
Edited by: JV
Serum C-reactive protein levels are linked to residual urgency symptoms in BPH patients
Wednesday, 19 October 2011- Urinary urgency is a common and bothersome symptom in patients with benign prostatic hyperplasia (BPH); this symptom may persist even after medical treatment.
Chronic inflammation has been reported...
Edited by: JV
FDA approves ED drug for enlarged prostate
Monday, 10 October 2011- Tadalafil (Cialis), currently marketed for erectile dysfunction, also may be used to treat benign prostatic hyperplasia (BPH), according to the US Food and Drug Administration (FDA).
The newly...
Saw palmetto fails to reduce enlarged prostate symptoms
Thursday, 29 September 2011- Doses of saw palmetto extract up to three times the standard did not reduce lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH), according to a randomised,...
Edited by: JV
BPH patients undergoing treatment have higher risk to develop PCa
Tuesday, 27 September 2011- Patients who are hospitalised or have surgery for benign prostatic hyperplasia (BPH) appear to be at higher risk for developing prostate cancer, researchers said here.
In a study utilising a large...
Edited by: JV
Aussie study shows safety of Prostatic Urethral Lift in BPH patients
Wednesday, 11 May 2011- Most surgical treatments for benign prostatic hyperplasia procedural involve the removal or destruction of prostate tissue and these approaches are commonly associated with treatment related morbidity....
Edited by: JV
Therapeutic Energy Applications in Urology
Tuesday, 15 February 2011, Minimally invasive procedures have progressively replaced open surgery in the field of urology. New developments in various technologies provide urologists with very effi cient devices, available for...
by: Prof.Dr. Paul Meria - Section Editor - Paris (FR)
Comparing plasma antibody levels against genitourinary pathogens in PCa and BPH patients
Tuesday, 2 November 2010- Researchers from Prague, Czech Republic, bagged the second prize for best abstract from Karl Storz at the recently concluded 10th Central European Meeting (CEM) held in Bratislava, Slovakia, for their...
Risk factors for LUTS/BPH progression- a view from the urologist's office
Wednesday, 6 October 2010- At the recently concluded 6th South Eastern European Meeting held in Istanbul, Turkey over the weekend, B. Cegar and colleagues from Belgrade, Serbia, won the first prize for best abstract from Karl...
Edited by: Joel Vega
